CA
TDAC

Crossingbridge Advisors’s Translational Development Acquisition Corp TDAC Stock Holding History

Crossingbridge Advisors’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.06M Buy
290,100
+40,100
+16% +$423K 0.55% 53
2025
Q4 		$250K Hold
250,000
– – 0.07% 91
2025
Q3 		$250K Sell
250,000
-150,000
-38% -$1.55M 0.13% 58
2025
Q2 		$4.11M Sell
400,000
-185,000
-32% -$1.88M 3.61% 7
2025
Q1 		$5.9M Buy
+585,000
New +$5.88M 3.1% 7

Other funds holding TDAC

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Crossingbridge Advisors's TDAC Position: Q1 2026 in Review

Crossingbridge Advisors increased its Translational Development Acquisition Corp (TDAC) stake by 16% in Q1 2026, buying an estimated $423K and bringing the position to 290,100 shares worth $3.06M. The position accounts for 0.55% of the portfolio, ranked #53.

Crossingbridge Advisors first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.9M in Q1 2025. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • Crossingbridge Advisors held 290,100 shares of Translational Development Acquisition Corp worth $3.06M as of Q1 2026.
  • Crossingbridge Advisors bought 40,100 Translational Development Acquisition Corp shares in Q1 2026, an estimated $423K.
  • Translational Development Acquisition Corp made up 0.55% of Crossingbridge Advisors's portfolio in Q1 2026, its #53 holding.
  • Crossingbridge Advisors first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
  • Crossingbridge Advisors's Translational Development Acquisition Corp position peaked at $5.9M in Q1 2025.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on Crossingbridge Advisors's 13F filing for Q1 2026, filed 14 May 2026.